This chapter explores significant developments in the SpaceTech sector, addressing issues like delayed earnings and stock performance. It also delves into the promising advances in CRISPR technology, highlighting a company's success in treating sickle cell disease amid fluctuating market sentiments. The chapter further examines small cap investing, particularly focusing on a Latin American travel company and its unique strategies within a competitive industry.
The fewer eyes on a market, the less efficient it’s going to be.
Bill Mann is the Director of Small Cap Research at The Motley Fool. He joined Ricky Mulvey to check on the small caps. They discuss:
- What investors should look for in younger companies.
- If Walgreens has a real turnaround story brewing.
- A rapidly growing travel company out of South America.
Companies discussed: WBA, SCHW, CRSP, DESP
Host: Ricky Mulvey
Guest: Bill Mann
Engineer: Tim Sparks
Learn more about your ad choices. Visit megaphone.fm/adchoices